Table 2 Subtype assignment by selected characteristics.
From: CRF07_BC is associated with slow HIV disease progression in Chinese patients
Characteristic | B | C | 01_AE | 07_BC | 08_BC | 55_01B | Minor | URF | Total | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | n | % | |
Sex | ||||||||||||||||||
Men | 2217 | 12.93 | 79 | 0.46 | 8201 | 47.82 | 4762 | 27.77 | 104 | 0.61 | 425 | 2.48 | 361 | 2.1 | 1002 | 5.84 | 17,151 | 100 |
Women | 266 | 25.17 | 33 | 3.12 | 284 | 26.87 | 323 | 30.56 | 55 | 5.2 | 8 | 0.76 | 53 | 5.01 | 35 | 3.31 | 1057 | 100 |
Age at diagnosis (years) | ||||||||||||||||||
< 18 | 33 | 36.67 | 3 | 3.33 | 20 | 22.22 | 26 | 28.89 | 1 | 1.11 | 1 | 1.11 | 3 | 3.33 | 3 | 3.33 | 90 | 100 |
18–24 | 222 | 10.63 | 10 | 0.48 | 987 | 47.27 | 661 | 31.66 | 12 | 0.57 | 31 | 1.48 | 40 | 1.92 | 125 | 5.99 | 2088 | 100 |
25–44 | 1246 | 15.02 | 50 | 0.6 | 3866 | 46.59 | 2225 | 26.81 | 87 | 1.05 | 117 | 1.41 | 167 | 2.01 | 540 | 6.51 | 8298 | 100 |
45–64 | 391 | 16.24 | 31 | 1.29 | 971 | 40.32 | 635 | 26.37 | 36 | 1.5 | 50 | 2.08 | 107 | 4.44 | 187 | 7.77 | 2408 | 100 |
≥ 65 | 44 | 13.25 | 5 | 1.51 | 111 | 33.43 | 114 | 34.34 | 11 | 3.31 | 5 | 1.51 | 13 | 3.92 | 29 | 8.73 | 332 | 100 |
Ethnicity | ||||||||||||||||||
Han | 1854 | 15.06 | 89 | 0.72 | 5734 | 46.56 | 3135 | 25.46 | 130 | 1.06 | 196 | 1.59 | 320 | 2.6 | 856 | 6.95 | 12,314 | 100 |
Uyghur | 8 | 2.71 | 1 | 0.34 | 5 | 1.69 | 277 | 93.9 | 0 | 0 | 0 | 0 | 2 | 0.68 | 2 | 0.68 | 295 | 100 |
Yi | 3 | 2.13 | 2 | 1.42 | 5 | 3.55 | 121 | 85.82 | 4 | 2.84 | 0 | 0 | 0 | 0 | 6 | 4.26 | 141 | 100 |
Others | 73 | 15.21 | 7 | 1.46 | 218 | 45.42 | 132 | 27.5 | 13 | 2.71 | 8 | 1.67 | 8 | 1.67 | 21 | 4.38 | 480 | 100 |
Transmission risk groups | ||||||||||||||||||
Heterosexual | 735 | 15.36 | 133 | 2.78 | 2041 | 42.65 | 1088 | 22.74 | 207 | 4.33 | 76 | 1.59 | 190 | 3.97 | 315 | 6.58 | 4785 | 100 |
MSM | 1640 | 12.01 | 39 | 0.29 | 6856 | 50.21 | 3672 | 26.89 | 39 | 0.29 | 372 | 2.72 | 254 | 1.86 | 783 | 5.73 | 13,655 | 100 |
Injecting drug user | 63 | 3.97 | 80 | 5.05 | 161 | 10.16 | 1018 | 64.23 | 105 | 6.62 | 3 | 0.19 | 36 | 2.27 | 119 | 7.51 | 1585 | 100 |
Blood transfusion | 378 | 82 | 0 | 0 | 41 | 8.89 | 31 | 6.72 | 3 | 0.65 | 0 | 0 | 7 | 1.52 | 1 | 0.22 | 461 | 100 |
Mother to child | 15 | 50 | 1 | 3.33 | 6 | 20 | 3 | 10 | 2 | 6.67 | 0 | 0 | 3 | 10 | 0 | 0 | 30 | 100 |
Region | ||||||||||||||||||
North | 3460 | 47.46 | 1738 | 23.84 | 49 | 0.67 | 101 | 1.39 | 1198 | 16.43 | 57 | 0.78 | 201 | 2.76 | 486 | 6.67 | 7290 | 100 |
North-east | 1211 | 55.7 | 460 | 21.16 | 15 | 0.69 | 21 | 0.97 | 281 | 12.93 | 13 | 0.6 | 52 | 2.39 | 121 | 5.57 | 2174 | 100 |
East | 2108 | 55.28 | 887 | 23.26 | 52 | 1.36 | 66 | 1.73 | 449 | 11.78 | 17 | 0.45 | 88 | 2.31 | 146 | 3.83 | 3813 | 100 |
Central-south | 1592 | 39.42 | 1153 | 28.55 | 97 | 2.4 | 243 | 6.02 | 686 | 16.98 | 19 | 0.47 | 52 | 1.29 | 197 | 4.88 | 4039 | 100 |
South-west | 480 | 20.17 | 1124 | 47.23 | 137 | 5.76 | 16 | 0.67 | 151 | 6.34 | 149 | 6.26 | 91 | 3.82 | 232 | 9.75 | 2380 | 100 |
North-west | 279 | 30.69 | 472 | 51.93 | 6 | 0.66 | 4 | 0.44 | 94 | 10.34 | 2 | 0.22 | 13 | 1.43 | 39 | 4.29 | 909 | 100 |
Period | ||||||||||||||||||
1994–2005 | 103 | 19.66 | 89 | 16.98 | 26 | 4.96 | 1 | 0.19 | 250 | 47.71 | 22 | 4.2 | 14 | 2.67 | 19 | 3.63 | 524 | 100 |
2006–2008 | 679 | 33.68 | 486 | 24.11 | 103 | 5.11 | 28 | 1.39 | 602 | 29.86 | 31 | 1.54 | 38 | 1.88 | 49 | 2.43 | 2016 | 100 |
2009–2011 | 2423 | 44.23 | 1639 | 29.92 | 70 | 1.28 | 108 | 1.97 | 843 | 15.39 | 105 | 1.92 | 115 | 2.1 | 175 | 3.19 | 5478 | 100 |
2012–2014 | 2586 | 49.16 | 1424 | 27.07 | 93 | 1.77 | 149 | 2.83 | 570 | 10.84 | 55 | 1.05 | 94 | 1.79 | 289 | 5.49 | 5260 | 100 |
2015–2017 | 1797 | 46.98 | 1108 | 28.97 | 33 | 0.86 | 66 | 1.73 | 377 | 9.86 | 27 | 0.71 | 101 | 2.64 | 316 | 8.26 | 3825 | 100 |
2018–2020 | 1568 | 44.04 | 1096 | 30.79 | 32 | 0.9 | 99 | 2.78 | 235 | 6.6 | 19 | 0.53 | 137 | 3.85 | 374 | 10.51 | 3560 | 100 |